Logo image of OSCR

OSCAR HEALTH INC - CLASS A (OSCR) Stock Fundamental Analysis

NYSE:OSCR - New York Stock Exchange, Inc. - US6877931096 - Common Stock - Currency: USD

12.62  +0.39 (+3.19%)

After market: 12.5005 -0.12 (-0.95%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to OSCR. OSCR was compared to 143 industry peers in the Insurance industry. OSCR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. OSCR has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

OSCR had negative earnings in the past year.
OSCR had a positive operating cash flow in the past year.
In the past 5 years OSCR reported 4 times negative net income.
In multiple years OSCR reported negative operating cash flow during the last 5 years.
OSCR Yearly Net Income VS EBIT VS OCF VS FCFOSCR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

OSCR has a worse Return On Assets (0.53%) than 72.03% of its industry peers.
OSCR has a Return On Equity of 2.51%. This is amonst the worse of the industry: OSCR underperforms 81.12% of its industry peers.
OSCR has a Return On Invested Capital (1.02%) which is in line with its industry peers.
Industry RankSector Rank
ROA 0.53%
ROE 2.51%
ROIC 1.02%
ROA(3y)-6.8%
ROA(5y)-11.11%
ROE(3y)-33.09%
ROE(5y)-46.23%
ROIC(3y)N/A
ROIC(5y)N/A
OSCR Yearly ROA, ROE, ROICOSCR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

Looking at the Profit Margin, with a value of 0.28%, OSCR is doing worse than 81.82% of the companies in the same industry.
OSCR has a Operating Margin of 0.63%. This is amonst the worse of the industry: OSCR underperforms 82.52% of its industry peers.
Industry RankSector Rank
OM 0.63%
PM (TTM) 0.28%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OSCR Yearly Profit, Operating, Gross MarginsOSCR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), OSCR is destroying value.
The number of shares outstanding for OSCR has been increased compared to 1 year ago.
OSCR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, OSCR has an improved debt to assets ratio.
OSCR Yearly Shares OutstandingOSCR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
OSCR Yearly Total Debt VS Total AssetsOSCR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 1.48, we must say that OSCR is in the distress zone and has some risk of bankruptcy.
OSCR has a better Altman-Z score (1.48) than 84.62% of its industry peers.
The Debt to FCF ratio of OSCR is 0.32, which is an excellent value as it means it would take OSCR, only 0.32 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.32, OSCR belongs to the top of the industry, outperforming 88.81% of the companies in the same industry.
OSCR has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of OSCR (0.30) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 0.32
Altman-Z 1.48
ROIC/WACC0.11
WACC8.92%
OSCR Yearly LT Debt VS Equity VS FCFOSCR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 0.15 indicates that OSCR may have some problems paying its short term obligations.
The Current ratio of OSCR (0.15) is better than 66.43% of its industry peers.
OSCR has a Quick Ratio of 0.15. This is a bad value and indicates that OSCR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Quick ratio value of 0.15, OSCR is doing good in the industry, outperforming 66.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.15
Quick Ratio 0.15
OSCR Yearly Current Assets VS Current LiabilitesOSCR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

6

3. Growth

3.1 Past

OSCR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.33%, which is quite impressive.
OSCR shows a strong growth in Revenue. In the last year, the Revenue has grown by 54.95%.
OSCR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 79.82% yearly.
EPS 1Y (TTM)98.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.06%
Revenue 1Y (TTM)54.95%
Revenue growth 3Y70.9%
Revenue growth 5Y79.82%
Sales Q2Q%67.11%

3.2 Future

The Earnings Per Share is expected to grow by 352.98% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 13.37% on average over the next years. This is quite good.
EPS Next Y3810.25%
EPS Next 2Y629.32%
EPS Next 3Y352.98%
EPS Next 5YN/A
Revenue Next Year20.69%
Revenue Next 2Y10.16%
Revenue Next 3Y13.37%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
OSCR Yearly Revenue VS EstimatesOSCR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
OSCR Yearly EPS VS EstimatesOSCR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 1 -1 -2 -3

4

4. Valuation

4.1 Price/Earnings Ratio

OSCR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
OSCR is valuated rather expensively with a Price/Forward Earnings ratio of 17.01.
Based on the Price/Forward Earnings ratio, OSCR is valued a bit more expensive than the industry average as 63.64% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of OSCR to the average of the S&P500 Index (21.38), we can say OSCR is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 17.01
OSCR Price Earnings VS Forward Price EarningsOSCR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, OSCR is valued a bit more expensive than 63.64% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, OSCR is valued a bit cheaper than 78.32% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.33
EV/EBITDA 20.54
OSCR Per share dataOSCR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

OSCR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as OSCR's earnings are expected to grow with 352.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y629.32%
EPS Next 3Y352.98%

0

5. Dividend

5.1 Amount

No dividends for OSCR!.
Industry RankSector Rank
Dividend Yield N/A

OSCAR HEALTH INC - CLASS A

NYSE:OSCR (4/28/2025, 7:00:00 PM)

After market: 12.5005 -0.12 (-0.95%)

12.62

+0.39 (+3.19%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-04 2025-02-04/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners87.89%
Inst Owner Change-0.44%
Ins Owners2.66%
Ins Owner Change24.15%
Market Cap3.16B
Analysts72
Price Target18.64 (47.7%)
Short Float %9.91%
Short Ratio3.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-14.42%
Min EPS beat(2)-25.82%
Max EPS beat(2)-3.02%
EPS beat(4)2
Avg EPS beat(4)28.98%
Min EPS beat(4)-25.82%
Max EPS beat(4)123.47%
EPS beat(8)5
Avg EPS beat(8)-1.42%
EPS beat(12)6
Avg EPS beat(12)-8.02%
EPS beat(16)8
Avg EPS beat(16)-12.4%
Revenue beat(2)1
Avg Revenue beat(2)-1.82%
Min Revenue beat(2)-5.21%
Max Revenue beat(2)1.57%
Revenue beat(4)3
Avg Revenue beat(4)0.45%
Min Revenue beat(4)-5.21%
Max Revenue beat(4)4.45%
Revenue beat(8)5
Avg Revenue beat(8)3.67%
Revenue beat(12)7
Avg Revenue beat(12)4%
Revenue beat(16)11
Avg Revenue beat(16)17.55%
PT rev (1m)-2.37%
PT rev (3m)-6.57%
EPS NQ rev (1m)-3.16%
EPS NQ rev (3m)15.98%
EPS NY rev (1m)-2.07%
EPS NY rev (3m)-3.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.25%
Revenue NY rev (1m)0.42%
Revenue NY rev (3m)-3.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 17.01
P/S 0.35
P/FCF 3.33
P/OCF 3.23
P/B 3.12
P/tB 3.12
EV/EBITDA 20.54
EPS(TTM)-0.02
EYN/A
EPS(NY)0.74
Fwd EY5.88%
FCF(TTM)3.79
FCFY30.05%
OCF(TTM)3.9
OCFY30.93%
SpS36.26
BVpS4.05
TBVpS4.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.53%
ROE 2.51%
ROCE 1.3%
ROIC 1.02%
ROICexc 1.55%
ROICexgc 1.8%
OM 0.63%
PM (TTM) 0.28%
GM N/A
FCFM 10.46%
ROA(3y)-6.8%
ROA(5y)-11.11%
ROE(3y)-33.09%
ROE(5y)-46.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover1.88
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 0.32
Debt/EBITDA 3.35
Cap/Depr 86.78%
Cap/Sales 0.31%
Interest Coverage 1.7
Cash Conversion 1094.05%
Profit Quality 3736.62%
Current Ratio 0.15
Quick Ratio 0.15
Altman-Z 1.48
F-Score7
WACC8.92%
ROIC/WACC0.11
Cap/Depr(3y)119.89%
Cap/Depr(5y)132.19%
Cap/Sales(3y)0.49%
Cap/Sales(5y)1.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.06%
EPS Next Y3810.25%
EPS Next 2Y629.32%
EPS Next 3Y352.98%
EPS Next 5YN/A
Revenue 1Y (TTM)54.95%
Revenue growth 3Y70.9%
Revenue growth 5Y79.82%
Sales Q2Q%67.11%
Revenue Next Year20.69%
Revenue Next 2Y10.16%
Revenue Next 3Y13.37%
Revenue Next 5YN/A
EBIT growth 1Y124.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year397.38%
EBIT Next 3Y114.16%
EBIT Next 5YN/A
FCF growth 1Y419.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y459.42%
OCF growth 3YN/A
OCF growth 5YN/A